Doctor profile · Federal record
Dr. MIROSLAWA JABLONSKI-COHEN, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · SELLERSVILLE, PA
- NPI 1437365194
- Accepts Medicare
- 27 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
670 LAWN AVE, SUITE 3A
SELLERSVILLE, PA 189601571
(215) 257-9500 - Mailing address
-
7701 ORCHARD WAY
WYNDMOOR, PA 190387640
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- June 30, 2010
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Pennsylvania #MD424269
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437365194. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,938
Distinct HCPCS
10
Medicare allowed
$196,389
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 706 | 399 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 639 | 381 | $134 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 341 | 282 | $8 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 285 | 140 | $82 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | 172 | $70 | |
93793 |
Anticoagulant management of patient taking warfarin | 114 | 11 | $12 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 106 | 37 | $24 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 85 | 84 | $135 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 79 | 29 | $31 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 73 | 29 | $123 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 149. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$708
Transactions
34
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $145.45 | |
| Merck Sharp & Dohme LLC | 4 | $69.15 | |
| Lexicon Pharmaceuticals, Inc. | 3 | $58.52 | |
| PFIZER INC. | 2 | $49.56 | |
| Esperion Therapeutics, Inc. | 2 | $46.83 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $45.44 | |
| Amgen Inc. | 2 | $39.05 | |
| SCPHARMACEUTICALS INC. | 2 | $34.49 | |
| AstraZeneca Pharmaceuticals LP | 2 | $33.30 | |
| Kiniksa Pharmaceuticals International, plc | 2 | $31.94 | |
| BIOTRONIK INC. | 1 | $27.80 | |
| Daiichi Sankyo Inc. | 1 | $22.64 | |
| Inspire Medical Systems, Inc. | 1 | $19.97 | |
| Novo Nordisk Inc | 1 | $19.33 | |
| Janssen Pharmaceuticals, Inc | 1 | $18.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,359
Patients
1,010
Total drug cost
$454,091
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 515 | 150 | $12,517 |
| Atorvastatin Calcium | Generic | 462 | 141 | $7,053 |
| Amlodipine Besylate | Generic | 329 | 100 | $3,063 |
| Eliquis (Apixaban) | Brand | 291 | 62 | $305,564 |
| Losartan Potassium | Generic | 269 | 79 | $4,364 |
| Lisinopril | Generic | 220 | 71 | $2,676 |
| Furosemide | Generic | 212 | 75 | $1,607 |
| Carvedilol | Generic | 201 | 62 | $2,756 |
| Metoprolol Tartrate | Generic | 190 | 53 | $2,278 |
| Rosuvastatin Calcium | Generic | 151 | 53 | $3,571 |